Mr. James Durward reports
YMI MARKETING CAMPAIGN UPDATE AND ANNUAL GENERAL AND SPECIAL MEETING RESULTS
Ndatalyze Corp.'s marketing contractor, BelieveCo (formerly VenturePlay), has provided a full update on the first of three phases for the YMI marketing campaign. As expected, phase 1 data revealed some indicated user experience (UX) changes that have been incorporated over the last few weeks. Phase 1 generated a small amount of revenue, which is expected to grow during phase 2. Phase 2 has now begun and includes a Canada-wide release (phase 1 was Alberta only), enhanced user tracking, influencer contracts, social media boosts and increased digital advertising spend. All three phases are expected to be completed prior to the corporation's fiscal year-end of Feb. 28, 2023, and all are fully financed by the corporation's existing cash balance.
The corporation further reports that all matters subject to shareholder voting at the corporation's annual and special meeting held on Nov. 30, 2022, were passed. Included is the shareholder approval to
wind-down or otherwise dispose of the extractor operations, which is believed necessary to clarify the corporation's future direction with the investment community and to address negative connotations associated with perceived drug-related operations. An additional factor is that the extractor operations have become marginally economic due to factors beyond the corporation's control, which factors the corporation believes will continue for the foreseeable future.
About Ndatalyze Corp.
Ndatalyze generates technology-based health-related solutions. Its machine-learning processed, on-line consumer mental health application known as YMI is based on the corporation's proprietary reference database consisting of over 1,200 biometric records complete with
associated electroencephalogram (EEG)
YMI has only recently begun its initial staged launch and, accordingly, the corporation cannot accurately predict if or when this application will become a cash flow generator.
We seek Safe Harbor.
© 2023 Canjex Publishing Ltd. All rights reserved.